Chain for claim_e1e3c14bb7d444bb
8 nodes. Root first; inputs below.
depth 0 · claim · via classify
claim_e1e3c14bb7d444bb
**Selected angle:** `counter_signal` ## One-sentence thesis The number of days in hospital was 41% lower in the triplet regimen than in the historical cohort (13 vs 22 days; P < .01). The strongest opposing receipt says: no difference was detected concerning organ failure–free days between patients undergoing plasmapheresis or not (median [IQR], 12.0 [8.0-14.0] vs 13.0 [8.0-14.0]; P = .94). **I…
sha256 42844be47d5c800a…
depth 1 · source
source_cc1f4e99f1fe48fb
**Selected angle:** `counter_signal` ## One-sentence thesis The number of days in hospital was 41% lower in the triplet regimen than in the historical cohort (13 vs 22 days; P < .01). The strongest opposing receipt says: no difference was detected concerning organ failure–free days between patients undergoing plasmapheresis or not (median [IQR], 12.0 [8.0-14.0] vs 13.0 [8.0-14.0]; P = .94). **…
sha256 e59db60a3adcaba0…
depth 1 · source
source_077e631f63494a84
{"publication_id": "6d41fa70-0327-4b55-b7b4-bad4c5449160", "traces": [{"candidate_sources": [{"doi": "10.1182/blood.2020008021", "study": "A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP", "url": null}, {"doi": "10.1111/bjh.13658", "study": "Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patient…
sha256 77fe9201cc613c25…
depth 1 · source
source_aa17de28170a4948
{"content_hash": null, "edges": [{"from": "6d41fa70-0327-4b55-b7b4-bad4c5449160", "to": "claim_1", "type": "contains_claim"}, {"from": "6d41fa70-0327-4b55-b7b4-bad4c5449160", "to": "claim_2", "type": "contains_claim"}], "nodes": [{"id": "6d41fa70-0327-4b55-b7b4-bad4c5449160", "title": "Therapeutic plasma exchange has a live counter-signal", "type": "publication"}, {"id": "claim_1", "text": "Interp…
sha256 1b49c126c1c0e2a6…
depth 1 · source
source_c573f096e4084d1d
{"contradictions": ["_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty f…
sha256 0fc281ebfc701517…
depth 1 · source
source_2503cb76195646c8
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness "A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Impact of severe ADAMTS13 deficiency on clinical presentation and outcom…
sha256 d2864db928328d7e…
depth 1 · source
source_a6e7696c4f4344f9
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "6d41fa70-0327-4b55-b7b4-bad4c5449160", "sources": [{"directness": "primary", "doi": "10.1182/blood.2020008021", "risk_of_bias": "not appraised in public sidecar", "study": "A regimen with caplacizumab, immunosuppression, and plasma excha…
sha256 ca657d05f726323b…
depth 1 · source
source_8ade1e4e784642bb
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 3805de320d573347…